Genotyping has expanded the number red blood cell (RBC) and platelet (PLT) antigens that can readily be typed, but often represents an additional testing cost. The analysis of existing genomic data offers a cost-effective approach. We recently developed automated software (bloodTyper) for determination of RBC and PLT antigens from whole genome sequencing. Here we extend the algorithm to whole exome sequencing (WES).
STUDY DESIGN AND METHODS: Whole exome
sequencing was performed on samples from 75 individuals. WES-based bloodTyper RBC and PLT typing was compared to conventional polymerase chain reaction (PCR) RHD zygosity testing and serologic and single-nucleotide polymorphism (SNP) typing for 38 RBC antigens in 12 systems (17 serologic and 35 SNPs) and 22 PLT antigens (22 SNPs) . Samples from the first 20 individuals were used to modify bloodTyper to interpret WES followed by blinded typing of 55 samples.
RESULTS:
Over the first 20 samples, discordances were noted for C, M, and N antigens, which were due to WES-specific biases. After modification, bloodTyper was 100% accurate on blinded evaluation of the last 55 samples and outperformed both serologic (99.67% accurate) and SNP typing (99.97% accurate) reflected by two Fy b and one N serologic typing errors and one undetected SNP encoding a Jk null phenotype. RHD zygosity testing by bloodTyper was 100% concordant with a combination of hybrid Rhesus box PCR and PCRrestriction fragment length polymorphism for all samples.
CONCLUSION:
The automated bloodTyper software was modified for WES biases to allow for accurate RBC and PLT antigen typing. Such analysis could become a routing part of future WES efforts.
I n recent years genotyping has greatly expanded the number of red blood cell (RBC) and human platelet (PLT) antigens that can readily be typed for both donors and recipients. RBC and PLT genotyping has improved transfusion medicine practice by facilitating complex reference laboratory workups, identifying antigennegative RBC and PLT donors, and expediting selection of reagent RBCs. RBC genotyping has also increased the availability of RBC units for routine extended antigen matching in chronically transfused patients and has enabled selection of antigen-matched units when compatibility cannot be demonstrated due to warm autoantibodies or drug interference in pretransfusion testing. Although single-nucleotide polymorphism (SNP)-based assays currently dominate the RBC and PLT genotyping market, next generation sequencing (NGS) approaches including targeted NGS, whole exome sequencing (WES), and whole genome sequencing (WGS) are being actively pursued by several groups. Conventional genotyping assays typically target a limited number of SNPs, which allows for the development of predefined rules for automated interpretation. Complex samples, especially those with changes not present on SNP assays, require further analysis by Sanger sequencing or an alternative approach. Many NGS blood typing efforts have simply expanded on this paradigm and only target a limited number of genetic regions with analysis requiring subject matter experts. However, the potential of NGS is much broader, since it can be used to detect essentially any nucleotide change or structural variation. Nevertheless, the volume and complexity of the NGS data make it difficult to evaluate the more than 2000 allelic variants across 46 RBC and six PLT antigen-associated genes. Although manual analysis of all antigen encoding genes is possible, 6 rapid and accurate automated interpretation of NGS data is desirable and necessary to scale for routine use. Toward this goal, the development of automated interpretative software has been described to analyze whole genomes for all molecularly understood RBC and PLT antigens. 5, 10, 17 We recently demonstrated the feasibility of using software (bloodTyper) to automatically type for all genetically defined RBC and PLT antigens from 330 whole genomes (WGS) with more than 99% accuracy when compared to conventional serologic and SNP typing for 38 RBC and 22 PLT antigens. 17 Compared to WGS, WES is less expensive and faster, 24 but
we reasoned that differences in method might require modifications to bloodTyper. For example, with WES, only exons and intronic regions near the exon boundaries are sequenced; thus relevant intronic regions might be missing. WES enrichment can also introduce capture biases leading to unequal sequence read depth of coverage that could affect copy number calculations and thereby impact the accuracy of detecting some antigens (i.e., C antigen).
Here, we present evidence that bloodTyper software can be used for automated RBC and PLT antigen typing from WES data. We describe specific modifications made to bloodTyper for WES data analysis including correcting for capture biases to more accurately calculate gene copy number. WES outperformed conventional hybrid Rhesus box polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (RFLP) assays for RHD zygosity determination. WES-based typing was more accurate than serology for extended antigen typing and was able to detect nucleotide changes not targeted by SNP assay.
MATERIALS AND METHODS

Study overview
Between October 2017 and August 2018, samples for RBC and DNA isolation were collected from 75 individuals undergoing WES as part of the MilSeq Project: Enabling Personalized Medicine through Exome Sequencing in the US Air Force (Clinical Trials Gov Number NCT03276637; see supplemental tables for self-identified ethnicities). DNA and RBC samples were frozen for follow-up testing if needed. In this substudy, we evaluated the performance of our automated RBC and PLT typing algorithm (bloodTyper) on WES data compared to serologic and SNP based typing (Fig. 1) . The first 20 samples were analyzed by bloodTyper and compared to serologic testing, SNP typing, and PCR-based RHD zygosity and the algorithm was modified to address WESspecific data challenges. The last 55 participant samples were then analyzed as blinded samples by bloodTyper.
Serologic typing
Blood samples were collected in EDTA, and conventional RBC serologic antigen typing was performed according to standard tube typing methods. 25 PCR-based RHD zygosity testing RHD zygosity testing was performed using two different PCR assays; detection of the hybrid Rhesus box by allelespecific PCR and by PCR-RFLP with PstI according to published methods. 30, 31 Briefly, allele-specific PCR targets a product of 1507 bp within the hybrid box sequence with the presence indicating at least one deleted RHD allele and absence of a product indicating RHD homozygote. The PCR-RFLP pattern differentiates RHD homozygote, hemizygote, and homozygote RHD deletion.
WES-based bloodTyper analysis
The custom interpretive blood typing software (bloodTyper) utilizes a curated antigen allele database (http:// bloodantigens.com) to analyze NGS data. 17 Variant calls for RBC and PLT antigen-associated genes and promoter regions were made using Genomic Analysis Tool Kit (GATK) v3.7-0-gcfedb67 (UnifiedGenotyper and EMIT_ALL_ SITES output mode) and saved as a variant calling format file (.vcf). 32 Sequencing coverage was extracted from the alignment file using BEDTools v2.17.0. 33 The Integrative
Genomics Viewer 34 was used as needed to verify coverage and sequence identity. bloodTyper used a 4× nucleotide calling cutoff when detecting antigen alleles. Toward the end of this study, the KANNO blood group antigen was identified to be located on the PRNP gene. 35 After adding the KANNO genetic change to our allele database all 75 samples were retrospectively typed for KANNO. bloodTyper also evaluated for the most common HbS sickle cell disease HBB gene variant c.20A>T 36 (see supplemental information for more details about WES sequencing workflow and copy number analysis method).
RESULTS
WES sequencing coverage
One limitation of WES is that nonexonic regions (e.g., upstream promoter and introns) are only sequenced if they are near exon boundaries. We estimated the effect of this limitation on RBC and PLT antigen typing by reviewing the antigen allele tables [37] [38] [39] for nonexonic nucleotide changes that impact antigen phenotype predictions. Other than the recently published transcription factor binding regions deep within A4GALT1 Intron 1 and upstream of XG that control the expression the P1 and Xg a antigens, [40] [41] [42] [43] [44] all other nonexonic changes associated with antigenic variation are located within 13 bp of an exon boundary. In fact, analysis of WES data from all 75 participants showed a similar depth of coverage pattern to previous WGS efforts, 6 with overall adequate sequencing coverage of all exons, but with some low-sequence coverage regions in nonantigen allele nucleotide positions within CR1, C4A, C4B, and several other genes ( Fig. 2A) . Other than the nucleotide positions that control the expression of the P1 and Xg a antigens, there was adequate sequencing coverage (>4×) for all other allele nucleotide positions with an average sequence depth of coverage of 159× for exons and 125× for nonexon nucleotide changes (Fig. 2B ). Of note, the very common silencing FY*B GATA mutation, c.-67T>C, found in those of African ancestry is within the exonic untranslated region of ACKR1 and this position is present in the WES data with an average 121× depth of coverage.
WES RBC and PLT antigen typing accuracy
Although all antigens with a known genetic basis and WES sequencing were interpreted by bloodTyper, it was only possible to evaluate the actual performance for antigens typed by confirmatory serologic and/or SNP-based typing (see supplemental tables for full typing results). As shown in Fig. 3 , in the first 20 WES samples there were eight discordances between WES-based bloodTyper analysis when compared with serologic and SNP typing: C (n = 5), M (n = 1), N (n = 1), and Fy b (n = 1). Repeat serologic typing showed the Fy b discordance was due to serologic typing error. The cause for the remaining discordances were due to WES-specific issues and modifications were made to bloodTyper to address them (see following sections for more details). The remaining 55 samples were analyzed with the modified WES-based algorithm, blinded to the information generated by the other antigen typing techniques for 38 RBC and 22 PLT antigens. There were four discordances, all of which underwent repeat serologic typing from frozen stored RBC samples. Two Fy b and one N typing discordance were shown to be serologic typing error. Additionally, a discordance was noted between a serologic Jk(b−) phenotype and 
WES RHD zygosity modifications
Whole exome sequencing depth of coverage for RHD was more variable than WGS-based analysis, 17 especially for RHD Exons 4, 7, 9, and 10 ( Fig. S1 , available as supporting information in the online version of this paper). However, it was possible to calculate copy number correction factors for these exons using homozygous RHD samples as a baseline (Fig. S2B ). As shown in Fig. 4A , the correction factors improved the copy number agreement across the RHD exons for all RHD zygosity states: 2× (homozygous), 1× (hemizygous), and 0× (null). Sequence read depth-based WES zygosity determination using both uncorrected and corrected exon copy numbers, agreed with a combination of conventional hybrid box PCR and PCR-RFLP based RHD zygosity testing with 29 RHD homozygous, 36 hemizygous, and 10 gene deletion samples (Fig. 4A) . One sample from a Hispanic individual (#41) was consistent with a homozygote by hybrid box assay, but hemizygote by PCR-RFLP and WES. Two samples from individuals of African ancestry (#11 and #40) indicated hemizygote by PCR-RFLP but homozygote by hybrid box assay and WES. Analysis of Exon 8 is difficult, since the human reference genome Exon 8 contains c.1136T found in RHD*DAU0, which causes Exon 8 sequencing from non-DAU0 individuals to incorrectly align. 17 In the first 20 samples, there was one (#11) that without correction appeared to have 2× aligned reads over RHD Exon 8, indicative of proper Exon 8 alignment suggesting a homozygous RHD*DAU0 individual (confirmed by PCR-RFLP). In the last 55, there were two additional samples (#29 and #40) with similar levels of 2× Exon 8 alignment, but these were heterozygous RHD*DAU0 individuals by PCR-RFLP (c.1136C/T). As such, it appears that WES can detect the presence of RHD*DAU0, but not its zygosity.
WES C antigen modifications
Determination of the C antigen requires special consideration when typing from NGS data because the C antigen is the result of an ancestral 4-kb gene conversion of RHD Exon 2 and surrounding intronic regions into RHCE. 45 As such RHCE*C Exon 2 sequence reads misalign to RHD Exon 2. 6, 11, 13, 17, 18 For WGS analysis, a copy number approach using sequence depth of coverage was useful to detect misalignment; 17 however, for WES data this approach did not immediately work (Figs. 3 and 4B ).
In the first 20 samples, serologic typing identified 10 samples with the C−c+ phenotype, which based on the above pattern should have 2× coverage across RHCE including Exon 2. However, over these 10 samples the RHCE depth of coverage was more variable than our previous WGS-based analysis 17 especially Exons 4, 6, 7, and 10 ( Fig. S1 ), which affects the baseline read depth used in the Exon 2 copy number calculation. To overcome this, RHCE correction factors were calculated to normalize the copy number for each exon ( 
WES M and N antigen modifications
M and N antigens require special consideration in NGSbased typing since the sequence alignment efficiency is low. This was shown to be true especially for the M antigen in a previous WGS study with 15× coverage that required a lower 2× calling cutoff. 17 However, as the MNS blood group system consists of three highly similar genes (GYPA, GYPB, and GYPE), misalignment to homologous genes might also account for the low M sequence read alignment. Analysis of GYPB and GYPE for misaligned M-specific GYPA sequences showed that as the M dosage (copy number) increased, the GYPA Exon 2 coverage decreased, and GYPE Exon 2 coverage increased (Fig. 5A ). This suggested that Exon 2 M allele reads were misaligning to GYPE Exon 2. Examination of GYPA, GYPB, and GYPE Exon 2 sequences are shown in Fig. 4A . M+ GYPA reads are homologous to GYPE (c.59C, c.71G, and c.72T) and homologous to N+ GYPA at c.38C. As shown in Fig. 4B , an understanding of the partial misalignment was used to look for M+ specific reads misaligned to GYPE using the following pattern: GYPA-specific c.38C along with the M+-specific c.59C (M c.38C_c.59C reads). This approach was able to correctly identify the M antigen status in 100% of the remaining 55 participant samples.
One N antigen discordance in the first 20 samples was due to two N-like sequence reads in an N− individual. This discordance was corrected by increasing the N antigen nucleotide cutoff from 2× to the usual 4× for other nucleotide changes. With this adjustment, bloodTyper was 100% accurate at typing the N antigen over the last 55 WES samples. Poststudy analysis showed that the cutoff adjustment prevented the incorrect calling of another sample with two N-like reads in an N− individual by serologic and SNP typing.
Clinically relevant antigen typings
In the MilSeq Project protocol, under institutional review board approval and with patient consent, extended RBC and PLT antigen profiles were summarized for each participant and provided to the physician as part of the clinical report designed for that study. Among the MilSeq Project participants, the absence of high-prevalence PLT antigens was revealed in two HPA-1a− and one HPA-2a− individuals. None of the participants lacked high-prevalence RBC antigens, but three were e−, which occurs in 2% to 3% of Caucasians and is uncommon less than 0.1% in other ethnic groups. Additional information of relevance for determining risk for alloantibody production for transfusion included three patients of African ancestry whose RBCs were typed as Fy 
DISCUSSION
In this study, we demonstrated the ability of automated analysis software, bloodTyper, to accurately type RBC and PLT antigens from whole exomes. After testing bloodTyper on the first 20 samples, modifications were made to the typing algorithm to accommodate for WES data, including copy number correction factors for RHD/RHCE exons and a novel method to detect GYPA M antigen-specific sequences misaligned to GYPE. With these modifications, WES-based typing was 100% accurate for all antigens tested by serologic and SNP typing methods. Our study is not the first to evaluate large-scale targeted NGS or WES for RBC antigen typing. 9, 11, [13] [14] [15] 20, 22 However, ours is the first to automate the analysis and to evaluate its use for extended antigen typing. Similar to our previous experience with WGS 17 the C, M, and N antigens required WES-specific algorithmic modifications. Previous WGS and WES studies have shown that RHD Exon 8 does not properly align since the reference sequence is RHD*DAU0. 6, 13, 17 Others have indicated that it was not possible to detect RHD*DAU0 in WES data. 13 In this study, we found that it was possible to detect the presence of RHD*DAU0, but we were not able to distinguish between homozygous and heterozygous RHD*DAU0.
Whole exome sequencing data performed well in determining RHD zygosity and was more reliable than conventional PCR methods in samples from minorities which are known to be discordant when altered RHD alleles are present. [47] [48] [49] [50] However, large RHD structural changes such as RHD*D-CE(2-9)-D, which were not present in any of the tested samples, would likely complicate WES-based zygosity calculations. Although it might be possible to use read depth-based copy number methods to call for these other large structural changes and then adjust the RHD zygosity call accordingly. After correcting for WES coverage biases, we were able to use sequence depth of coverage copy number to accurately type for the C antigen. Such an approach is vital here, since the intronic 109-bp insertion in Intron 2 is often used in SNPbased assays as a marker for the C antigen, but this region is not sequenced by WES. In contrast to our findings with WGS we were not able to call M antigen simply by lowering the calling cutoff from 4× to 2×, since even at 2× there was a false M− call. However, using a defined sequence read pattern capable of finding GYPA M+ specific reads that misaligned to GYPE, M antigen typing was 100% accurate over the last 55 samples. This same technique should also be usable with WGS data for more robust M+ antigen typing, especially in analysis of genomes with lower than 15× coverage. Similar to our previous WGS bloodTyper validation, 17 we also encountered serologic which was not found in this homozygous c.265C sample. It should also be noted that although allelic dropout of c.265T could account for this discordance, this is unlikely given that the 146× depth of coverage for c.265C in this sample was similar to other samples at this same position (mean of 194× with a standard deviation of 38×).
A limitation of the current study is that not every known RBC or PLT antigen could be tested for comparison because some antigens are very rare or only common in specific ethnicities. Similarly, the data set did not include samples with hybrid Rh and MNS changes. The copy number analysis algorithm will likely require future optimizations to address Rh and MNS hybrids. Full validation of bloodTyper for all known antigenic backgrounds will require the testing of additional data sets representing untested phenotypes. Other than for the P1 and Xg a nucleotide changes, all other nucleotide changes were within 13 bp of exons and captured by WES. There are also rare weak A and B 3 subgroup nucleotide changes, not yet added to official allele tables, in ABO Intron 1 and upstream gene promoter regions that would not be detected by WES. The ability to detect less common null nucleotide changes is an important advantage of both WGS and WES over available SNP typing assays. As shown here, the sequencing of intronic regions near exon boundaries covers the vast majority of allele nucleotide changes, including a Jk null c.342−1A nucleotide change not detected by the SNP assay in a participant of self-declared Native Hawaiian/Pacific Islander/Asian ancestry (#70). Although the c.342−1A nucleotide is very rare in most ethnicities, it is present in 1.1% of Asians (chr18:43314238A). 52 Although bloodTyper detected the c.342−1A nucleotide change, it issued a warning since it could not cis/trans phase c.342 −1A with the JK*A and JK*B nucleotide changes. While c.342−1A has been reported on both JK*A and JK*B backgrounds, it is more prevalent on JK*B. Therefore, future modifications to bloodTyper will impute this and other allele haplotypes based on prevalence with notation of potential exceptions. As additional genomic data sets are made available, ethnicity-based haplotype frequencies should allow for even better imputation of short read NGS data. In addition, long and linked read sequencing NGS will increase this advantage since it should be able to cis/trans phase many more heterozygous changes like the one found here. In summary, we have modified an automated WGSbased antigen typing software bloodTyper to accurately type RBC and PLT antigen from WES data. bloodTyper-based analysis could become a routine part of WES analysis. Given that WES is less expensive than WGS, it opens up the possibility of routinely using WES to aid in complex alloantibody workups. In addition, this work demonstrates the flexibility of bloodTyper to adapt to different data types, which in the future could include targeted NGS, high-density SNP arrays, and long-read NGS. This flexibility should also make it possible to extend bloodTyper to analyze for human neutrophil antigens and hemoglobinopathies.
